Education
About Us
Working with TipRanks
Follow Us
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Total Valuation
China Shineway Pharmaceutical Group Limited has a market cap or net worth of HK$5.72B. The enterprise value is HK$751.47M.
Market CapHK$5.72B
Enterprise ValueHK$751.47M
Share Statistics
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding827,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Shineway Pharmaceutical Group Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.40M
Profits Per Employee383.74K
Employee Count3,232
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of China Shineway Pharmaceutical Group Limited is ―. China Shineway Pharmaceutical Group Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio1.40
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, China Shineway Pharmaceutical Group Limited had revenue of 4.52B and earned 969.51M in profits. Earnings per share was 1.28.
Revenue4.52B
Gross Profit3.39B
Operating Income975.53M
Pretax Income1.24B
Net Income969.51M
EBITDA1.42B
Earnings Per Share (EPS)1.28
Cash Flow
In the last 12 months, operating cash flow was 932.63M and capital expenditures -144.32M, giving a free cash flow of 788.31M billion.
Operating Cash Flow932.63M
Free Cash Flow788.31M
Free Cash Flow per Share0.95
Dividends & Yields
China Shineway Pharmaceutical Group Limited pays an annual dividend of HK$0.579, resulting in a dividend yield of 7.67%
Dividend Per ShareHK$0.579
Dividend Yield7.67%
Payout Ratio10.00%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change-10.63%
50-Day Moving Average8.31
200-Day Moving Average8.56
Relative Strength Index (RSI)38.17
Average Volume (3m)1.50M
Important Dates
China Shineway Pharmaceutical Group Limited upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateApr 30, 2025
Financial Position
China Shineway Pharmaceutical Group Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, China Shineway Pharmaceutical Group Limited has paid 270.74M in taxes.
Income Tax270.74M
Effective Tax Rate―
Enterprise Valuation
China Shineway Pharmaceutical Group Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
China Shineway Pharmaceutical Group Limited has HK$5.91B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -HK$5.61B billion.
Cash & Marketable SecuritiesHK$5.91B
Total Debt¥0.00
Net Cash-HK$5.61B
Net Cash Per Share-HK$6.78
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for China Shineway Pharmaceutical Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-18.09%
EPS Growth Forecast-15.08%